Canada · Delayed Price · Currency is CAD Cresco Labs Statistics
Total Valuation
Cresco Labs has a market cap or net worth of CAD 420.75 million. The enterprise value is 1.08 billion.
| Market Cap | 420.75M |
| Enterprise Value | 1.08B |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cresco Labs has 372.35 million shares outstanding. The number of shares has increased by 3.63% in one year.
| Current Share Class | 355.59M |
| Shares Outstanding | 372.35M |
| Shares Change (YoY) | +3.63% |
| Shares Change (QoQ) | +29.68% |
| Owned by Insiders (%) | 2.95% |
| Owned by Institutions (%) | 17.69% |
| Float | 346.26M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| PB Ratio | 1.13 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 28.86 |
| P/OCF Ratio | 6.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.47, with an EV/FCF ratio of 74.02.
| EV / Earnings | n/a |
| EV / Sales | 1.17 |
| EV / EBITDA | 5.47 |
| EV / EBIT | 12.13 |
| EV / FCF | 74.02 |
Financial Position
The company has a current ratio of 1.78, with a Debt / Equity ratio of 2.25.
| Current Ratio | 1.78 |
| Quick Ratio | 0.53 |
| Debt / Equity | 2.25 |
| Debt / EBITDA | 4.26 |
| Debt / FCF | 57.66 |
| Interest Coverage | 1.02 |
Financial Efficiency
Return on equity (ROE) is -36.06% and return on invested capital (ROIC) is 7.73%.
| Return on Equity (ROE) | -36.06% |
| Return on Assets (ROA) | 3.00% |
| Return on Invested Capital (ROIC) | 7.73% |
| Return on Capital Employed (ROCE) | 5.57% |
| Weighted Average Cost of Capital (WACC) | 10.03% |
| Revenue Per Employee | 318,853 |
| Profits Per Employee | -49,419 |
| Employee Count | 2,900 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 3.25 |
Taxes
In the past 12 months, Cresco Labs has paid 12.67 million in taxes.
| Income Tax | 12.67M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.84% in the last 52 weeks. The beta is 1.72, so Cresco Labs's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | -36.84% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 52.13 |
| Average Volume (20 Days) | 71,755 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cresco Labs had revenue of CAD 924.67 million and -143.31 million in losses. Loss per share was -0.40.
| Revenue | 924.67M |
| Gross Profit | 461.64M |
| Operating Income | 88.97M |
| Pretax Income | -147.17M |
| Net Income | -143.31M |
| EBITDA | 157.83M |
| EBIT | 88.97M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 46.68 million in cash and 840.72 million in debt, with a net cash position of -794.04 million or -2.13 per share.
| Cash & Cash Equivalents | 46.68M |
| Total Debt | 840.72M |
| Net Cash | -794.04M |
| Net Cash Per Share | -2.13 |
| Equity (Book Value) | 373.98M |
| Book Value Per Share | 1.37 |
| Working Capital | 153.30M |
Cash Flow
In the last 12 months, operating cash flow was 61.62 million and capital expenditures -47.04 million, giving a free cash flow of 14.58 million.
| Operating Cash Flow | 61.62M |
| Capital Expenditures | -47.04M |
| Depreciation & Amortization | 67.11M |
| Net Borrowing | -81.80M |
| Free Cash Flow | 14.58M |
| FCF Per Share | 0.04 |
Margins
Gross margin is 49.92%, with operating and profit margins of 9.62% and -15.50%.
| Gross Margin | 49.92% |
| Operating Margin | 9.62% |
| Pretax Margin | -15.92% |
| Profit Margin | -15.50% |
| EBITDA Margin | 17.07% |
| EBIT Margin | 9.62% |
| FCF Margin | 1.62% |
Dividends & Yields
Cresco Labs does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.63% |
| Shareholder Yield | -3.63% |
| Earnings Yield | -34.06% |
| FCF Yield | 3.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Cresco Labs is 2.50, which is 131.48% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 2.50 |
| Price Target Difference | 131.48% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 2.50% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Cresco Labs has an Altman Z-Score of -0.66 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.66 |
| Piotroski F-Score | 5 |